Healthcare -
Biotechnology - NASDAQ - US
$ 4.4186
-5.79 %
$ 168 M
Market Cap
-2.76
P/E
OBIO - COST OF REVENUE
Cost of Revenue OBIO - Orchestra BioMed Holdings, Inc.
186 K
LAST VALUE
-3.32%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR